Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses (2013 - 2026)

Viridian Therapeutics, Inc.\DE's (VRDN) quarterly Other Operating Expenses came in at -$672000.0 in Q1 2026, down 1766.67% year-on-year from $40320.0 in Q1 2025, and up 68.24% quarter-over-quarter from -$2.1 million in Q4 2025.

Viridian Therapeutics, Inc.\DE (VRDN) Other Operating Expenses (2013 - 2026) Analysis & Trends

Viridian Therapeutics, Inc.\DE's Other Operating Expenses history runs 8 years deep, the most recent figure standing at -$672000.0 for Q1 2026.

  • On a quarterly basis, Other Operating Expenses fell 1766.67% year-over-year to -$672000.0 in Q1 2026; TTM through Mar 2026 was -$2.3 million, a 379.47% decrease from a year earlier, with the FY2025 full-year figure at -$1.7 million, down 427.71% from the prior year.
  • Other Operating Expenses advanced to -$672000.0 in Q1 2026 per VRDN's latest filing, from -$2.1 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $33.7 million in Q4 2022 and bottomed at -$2.1 million in Q4 2025.
  • The 4-year median for Other Operating Expenses is -$195000.0 (2024), against an average of $4.4 million.
  • Across the five-year window, Other Operating Expenses surged 332.31% in 2025 and plunged 1766.67% in 2026, its largest moves.
  • Year by year, Other Operating Expenses stood at $33.7 million in 2022, then tumbled by 100.76% to -$256000.0 in 2024, then plunged by 726.56% to -$2.1 million in 2025, then surged by 68.24% to -$672000.0 in 2026.
  • Per Business Quant, the three latest VRDN Other Operating Expenses figures stand at -$672000.0 (Q1 2026), -$2.1 million (Q4 2025), and $453000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Viridian Therapeutics, Inc.\DE 631.55 Mn 631.55 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -672,000.00
Dec 31, 2025 -2.12 Mn
Sep 30, 2025 453,000.00
Mar 31, 2025 -36,000.00
Dec 31, 2024 -256,000.00
Sep 30, 2024 -195,000.00
Dec 31, 2022 33.72 Mn
Dec 31, 2020 69.86 Mn
Dec 31, 2015 912,000.00
Sep 30, 2015 830,000.00
Jun 30, 2015 872,000.00
Mar 31, 2015 1.19 Mn
Dec 31, 2014 761,000.00
Sep 30, 2014 1.07 Mn
Jun 30, 2014 1.08 Mn
Mar 31, 2014 766,000.00
Dec 31, 2013 460,484.00
Sep 30, 2013 813,141.00
Jun 30, 2013 625,874.00